21BBA111.ET Report Part 2

BM310.
3 - EXECUTIVE TRAINING PROJECT REPORT – PART 2 2024
Executive Training report (Part 2)

On
Innovations in Poultry healthcare products:
A case study of Poshak Medicines Pvt. Ltd.
Submitted to:
Dr. Archana Sarkar
Assistant professor
Indukaka Ipcowala Institute of Management
Charotar University of science and technology (CHARUSAT)
Changa – 388421, TA: Petlad, dist. Anand, Gujarat
Prepared by:
PATEL AAYUSH RAJESH
21BBA111
BBA 6th semester
April 2024
1
BM310.3 - EXECUTIVE TRAINING PROJECT REPORT – PART 2 2024
ACKNOWLEDGEMENT
I would like to express my sincere gratitude to all those who have contributed to the successful completion of
my internship and the preparation of this report. First and foremost, I extend my deepest appreciation to the
Poshak group for providing me with the opportunity to undertake my internship. I would also like to
acknowledge my faculty guide Professor Dr. Archana Sarkar for guiding and assisting me throughout the
project and also a special thanks to Dr. Binit Patel, Principal IIIM, CHARUSAT, and Dr. Reshma Sable, Dean
IIIM, CHARUSAT for providing me the necessary guidance and support. Lastly, I am grateful to my family and
friends for their unwavering support and encouragement throughout this journey.
2
STUDENTS DECLARATION
I hereby declare that the Executive Training Project Report-II entitled “Innovations in Poultry healthcare
products: A case study of Poshak Medicines”. undertaken by Patel Aayush Rajesh, ID no. 21BBA111, is the
result of my own work and my indebtedness to other work publications, references, if any, has been duly
acknowledged. If I am found guilty of copying from any other report or published information and showing it
as my original work, or extending plagiarism limit, I understand that I shall be punishable by the
institute/university, which may include ‘Incomplete Grade’ in examination or any other punishment that
institute/university may decide.
Aayush Patel (21BBA111)

_______________________
Charotar University of Science and Technology
Date: 19/03/2024
3
Place: Anand
CERTIFICATE
This is to certify that the project report entitled “Innovation in Poultry healthcare products: A case study on
Poshak medicines” submitted to the Department of Management Studies, Charotar University of Science and
Technology, in partial fulfilment for the award of the degree of Bachelor of Business Administration, is a record
of bonafide work carried out by Mr. Patel Aayush Rajesh Roll No. 21BBA111, under my supervision and
guidance.
Dr. Archana Sarkar

Assistant professor
_______________
Charotar University of Science and Technology
4
Date: 19/03/2024
Place: Changa
TABLE OF CONTENTS
PARTICULARS PAGE NO.
Chapter 1: Introduction and background of study 6

Chapter 2: Literature review 8
 Published information in a particular subject area.
 To be collected from journal articles that comment on or analyses
research.
Chapter3: Research methodology 12
 Objective of the study
 Methodology (research design, data collection, sampling method,
data analysis tools)
 Limitations of the study
 Rationale of the study
Chapter 4: Data analysis and interpretation 17

Chapter 5: Findings & conclusion, recommendation, Future scope of 21
the study
Bibliography and references 25
Questionnaire 26
LIST OF TABLES
SR. NO PARTICULARS PAGE NO.
Table 1 Awareness and perception of innovation 19
Table 2 Effectiveness, satisfaction, value perception and recommendation likelihood 19
LIST OF FIGURES
SR. NO PARTICULARS PAGE NO.
5
Figure 1 Most significant innovations 20
Figure 2 Future innovations expectations 20
CHAPTER 1: INTRODUCTION AND BACKGROUND OF STUDY
Introduction
This study investigates the pioneering advancements in poultry healthcare products through a detailed
examination of Poshak Medicines Pvt Ltd, a subsidiary of the esteemed Poshak Group. Established in 2001,
Poshak Group boasts over 25 years of expertise in the poultry industry, evolving from a focus on feed
manufacturing to comprehensive involvement in various facets of poultry farming.
In 2018, recognizing the pivotal role of healthcare in poultry management, Poshak Group extended its reach by
introducing Poshak Medicines Pvt Ltd. This strategic move marked the company’s foray into supplying
essential poultry health products, including medicines, vaccines, and feed supplements.
The study will delve into the background of Poshak Group, its trajectory in the poultry industry, and the
strategic expansion into healthcare products. With a broad geographical presence covering states such as
Rajasthan, Haryana, Jammu, Madhya Pradesh, Uttar Pradesh, Maharashtra, and a prominent position in the
Gujarat poultry industry, Poshak Medicines Pvt Ltd signifies a commitment to serving a diverse and expansive
customer base.
Poshak Group’s dedication to quality and customer satisfaction is not only a testament to its extensive
experience but is also reflected in the user-centric design of its website, ensuring a seamless experience for
customers seeking poultry-related products and services.
This investigation aims to unravel the innovative approaches undertaken by Poshak Medicines Pvt Ltd,
including collaborations with reputable pharmaceutical companies, cost-effective solutions, and a
comprehensive product range categorized into feed and care, oral and liquid medicines, and vaccines. Through
this study, we seek to provide insights into the impact of these innovations on the poultry healthcare landscape
and their implications for the broader industry.
Background of the study

6
The poultry industry, being multifaceted, requires a comprehensive approach to address the health and well-
being of poultry flocks. Poshak Medicines Pvt Ltd has strategically ventured into this domain to contribute
significantly to the industry’s growth. By collaborating with reputable pharmaceutical companies, the company
has been at the forefront of accessing the latest and most advanced treatments for poultry health.
As Poshak Medicines Pvt Ltd marks its presence in regions such as Rajasthan, Haryana, Jammu, Madhya
Pradesh, Uttar Pradesh, Maharashtra, and Gujarat, the geographical spread of its facilities reflects a
commitment to catering to a diverse customer base. This study aims to explore the innovations introduced by
Poshak Medicines Pvt Ltd and evaluate their impact on the poultry industry, customer satisfaction, and the
company’s market standing.
By understanding the evolution of Poshak Medicines Pvt Ltd since its inception in 2018 and analyzing its
strategic approach to product development, market penetration, and collaborations, this research seeks to
uncover valuable insights. Through a detailed examination of the company’s offerings, customer feedback,
market presence, and economic impact, the study aims to contribute to a broader understanding of the
innovative dynamics within the poultry health products sector.
7
CHAPTER 2: LITERATURE REVIEW
The literature review for the research on “Innovations in Poultry Healthcare Products: A Case Study on Poshak
Medicines Pvt Ltd” involves a comprehensive analysis of published information in the field of poultry
healthcare innovations.
1) Innovation in managing health of broiler, breeders and broiler progeny by John Brake (2015):
John Brake explores paradigms and paradoxes in the poultry industry, notably the dilemma of
stimulating immunity versus feed-efficient growth with antibiotic growth promoters (AGPs). The
discussion emphasises the need to strategically manage gastrointestinal tract (GIT) function in broiler
breeders and progeny without compromising immunity. A paradigm related to feed particle size is
identified. While pelleting aims for feed sanitation and increased intake efficiency, an oversight arises
from ignoring the avian species’ evolved stomach compartments. Cloacal contamination emerges as a
critical concern linked to broiler health issues. Theorised factors include feed particle size, dietary
elements, and acid-base balance.
2) How improving animal welfare standards can benefit poultry industry and consumers by Michael
Appleby (2018): In contemplating the future of poultry farming, a multitude of factors must be
weighed, encompassing local and global dimensions. Among these factors, animal welfare emerges as a
pivotal consideration, influencing the industry, consumers, and the well-being of the birds themselves.
Achieving sustainability, often deemed humanity’s primary challenge, demands a delicate balance
between environmental, economic, and ethical aspects. While environmental and economic
considerations have traditionally taken precedence, ethical aspects, encompassing both human and
animal welfare, are integral for policy acceptability and applicability. In the context of egg and poultry
meat production, the trinity of environmental, economic, and ethical factors directs attention towards
8
animal management and welfare. Scientific research in this domain addresses pressing issues such as
bone breakage, injurious pecking, breast blisters, and foot pad dermatitis. The outcome of this research
has led to shifts in policies and standards adopted by producers, retailers, national governments, and
intergovernmental organisations.
3) Impact of genetic diversity of IBV on vaccine selection and efficacy by J.J De Wit (2016):
Infectious Bronchitis Virus (IBV) poses a significant threat to chickens, impacting respiratory, renal, and
reproductive systems with economic and welfare implications. Effective control of IBV necessitates
vaccination in both broilers and laying birds, given the virus’s ability to infect chickens of all ages and
types. IBV presents a challenge due to its diverse variants, outnumbering available vaccines in the field.
Homologous vaccines, when appropriately applied, offer high protection levels, but cross-protection by
heterologous vaccines varies widely. Combining different vaccines can enhance cross-protection,
providing a more comprehensive defence against various field strains. For vaccine producers,
understanding the prevalent strains aids in selecting the most effective combination to induce broad
cross-protection against relevant field strains.
4) Infectious bronchitis: hatchery vaccination strategy against emerging against IBV variants by
Roberto Soares (2019): Infectious Bronchitis (IB) is caused by a chicken coronavirus, a member of the
family Coronaviruses. The virus, known as Infectious Bronchitis Virus (IBV), is enveloped and carries a
single-stranded RNA genome. Its highly contagious nature allows for horizontal transmission through
aerosol inhalation, ingestion of feces, or consumption of contaminated feed or water. IBV can persist in
birds and feces for extended periods. The disease primarily manifests in the respiratory tract, replicating
in epithelial cells, but also affects various other epithelial cells, including those in the intestines,
kidneys, and oviducts. One notable characteristic of IBV is its capacity to mutate, leading to the
generation of multiple antigenic variants. This mutability poses challenges for disease control and
vaccine development. The ongoing mutations contribute to the complexity of managing and preventing
Infectious Bronchitis in poultry flocks.
5) Nanotechnology innovations for increasing the productivity of poultry and the prospective of nano
biosensors by Nima Komeli (2023): Nanotechnology emerges as an innovative and promising
technology with extensive applications and socioeconomic potential in the poultry industry.
Nanoparticles (NPs) offer advantages such as high absorption, increased bioavailability, and more
effective delivery to target tissues compared to bulk particles. Diverse nano materials with varying
9
forms, sizes, shapes, applications, surface modifications, charges, and natures are available.
Nanoparticles play a crucial role in medicine delivery, allowing targeted delivery to specific sites in the
body, thereby reducing toxicity and side effects. The review article explores different mechanisms
through which nanoparticles exert their actions. Despite the vast benefits, concerns about the safety and
potential hazardous effects of nanoparticles in poultry production should be acknowledged. The focus of
the review is on the types, manufacture, mechanisms of action, and applications of nanoparticles,
addressing both their positive impacts and potential risks in the context of poultry farming.
6) New technologies and products for livestock and poultry bone processing by Min Zhang (2024):
Livestock and poultry bones, often by-products of meat processing and slaughter, are valuable reservoirs
of highly nutritious natural substances. However, technological limitations have impeded their optimal
utilisation. Recognising their nutritional richness, it becomes essential to identify and explore effective
processing technologies for these bone resources. This pursuit aims to address the escalating demands of
the food industry, unlocking the potential of livestock and poultry bones as valuable and sustainable
sources of nutrition.
7) Enhancing innovative ideas implementation: a study of Finland’s poultry industry by Eric Kolog
(2017): This study delves into the factors influencing the successful implementation of innovative ideas
in Finland’s poultry industry, with a primary focus on chicken production. Conducted as qualitative
research, the study utilised interviews and surveys to gather comprehensive insights from 79 individual
respondents, including employees from a case company and academia. Key findings suggest that the
innovation implementation process is similar, whether the idea originates from internal research or an
external source, aligning with established innovation process model theories. To integrate innovative
ideas successfully, alignment with regulations, particularly in animal welfare and the environment, is
crucial. The study emphasises the importance of extensive collaboration and partnerships in simplifying
the industry’s implementation processes.
8) Poultry vaccines: an innovation for food by Hair Bejo (2011): This study investigates factors
influencing the successful implementation of innovative ideas in Finland’s poultry industry, focusing
predominantly on chicken production. Employing qualitative research methods, including interviews
and surveys, data was gathered from 79 individual respondents, comprising employees from a case
company and academia. Key findings reveal that the innovation implementation process is akin,
10
regardless of the idea’s origin, be it from internal research or an external source. This suggests a linkage
to established innovation process model theories. Successful integration of innovative ideas hinges on
alignment with regulations, especially in animal welfare and the environment. The study underscores the
significance of extensive collaboration and partnerships in streamlining the industry’s implementation
processes.
9) Improving the quality and safety of eggs by Jesus Arango (2014): The focus on enhancing both the
quality and safety of eggs in breeding companies, particularly those producing egg-laying hens, has
intensified. Recent innovations and technological advancements have significantly contributed to
achieving this goal. Precision in measurements is now crucial for making objective assessments of egg
quality and safety. From a genetic standpoint, animals are selectively bred to possess the potential for
producing eggs with superior external and internal quality.
10) Optimising poultry production through advanced monitoring and control systems by Shai
George (2023): Poultry farming, a significant global industry producing over 120 million tons of
various poultry meats annually, faces challenges related to animal welfare, environmental impact, and
economic sustainability due to its intensive nature. This paper explores the potential of advanced
monitoring and control systems to address these challenges. Current practices involve basic regulation
of environmental conditions, feeding, and health monitoring, leading to inconsistencies in growing
conditions and flock health. The proposed solution involves intelligent systems that enable real-time
tracking and automatic adjustments to temperature, lighting, ventilation, and feeding. Automated poultry
farming processes enhance standardisation, ensuring all birds in a flock experience uniform conditions
tailored to their needs. Algorithmic feeding plans provide nutritionally optimal diets, while climate
control maintains ideal temperatures and air quality.
11) Egg innovations and strategies for improvement by Patricia Hester (2016): This study
comprehensively explores the egg production process from development to human consumption. The
book covers various aspects including consumer acceptance, quality control, regulatory considerations,
cost and risk analyses, and research trends. The book emphasises eggs as wholesome and versatile
foods, providing a balanced array of essential nutrients and serving as staples in human diets. Emerging
strategies focus on enhancing egg composition through fortification or biological enrichment of hen’s
feed with polyunsaturated fatty acids, antioxidants, vitamins, or minerals. However, the book
acknowledges that eggs can pose challenges as a potential source of food-borne diseases or pollutants,
affecting human health, egg production, and commercial viability. Written by an international team of
11
experts, the book offers a unique overview of the biology and science of egg production, nutrient
profiling, disease management, and methods to enhance both the quantity and quality of egg production.
12) Role of proper steam conditioning to feed pelleting efficiency and feed value by Steven Goh
(2020): This paper emphasises the critical role of proper steam conditioning in achieving excellence in
feed pelleting, highlighting its potential direct impact on animal health and productivity. It addresses the
need for a balanced approach to steam conditioning, considering feed pellet quality, machine throughput
efficiency, and the nutritional value of processed pellet feeds. The discussion delves into the existing
challenges in feed pelleting and advocates for a reevaluation of industry practices and engineering
norms. The author stresses that understanding how to work with steam correctly is paramount to
enhancing pellet mill performance, productivity, and the quality of pellet feeds.
CHAPTER 3: RESEARCH METHODOLOGY
I) Objective of the study
1) Assessing customer satisfaction: To measure and analyze the overall satisfaction levels of customers
using Poshak Medicines’ poultry healthcare products, focusing on factors such as quality, pricing, and
availability.
2) Evaluating awareness and perception of innovation: To gauge the awareness among respondents
regarding recent innovations introduced by Poshak Medicines in their poultry healthcare product line
and to assess their perception of the company’s innovativeness compared to other competitors in the
poultry healthcare sector.
3) Analysing product effectiveness and impact: To examine and understand the perceived effectiveness of
Poshak Medicines’ poultry healthcare products and their impact on flock health, disease prevention, and
overall productivity within the poultry farming operations.
4) Examining perceived value and pricing: To investigate how respondents perceive the value for cost of
Poshak Medicines’ poultry healthcare products, focusing on the competitive pricing strategy and its
alignment with customer expectations.
12
5) Assessing ease of access and information: To analyse the ease with which respondents access
information about Poshak Medicines’ poultry healthcare products and to evaluate the sufficiency of
communication channels in delivering relevant product information.
6) Identifying areas for improvement: To identify specific areas where respondents believe Poshak
Medicines could improve or innovate further in their poultry healthcare product offerings, capturing
insights into potential enhancements.
7) Understanding future expectations and preferences: To gain insights into the features or innovations that
respondents would like to see in future poultry healthcare products from Poshak Medicines, providing
guidance for future product development.
8) Determine likelihood to recommend: To investigate any challenges or obstacles faced by respondents in

utilising or acquiring Poshak Medicines’ products for their poultry operations, identifying potential
areas for operational improvement.
II) Methodology
1) Research design.
i) Qualitative Case Study Design: A qualitative research approach will be employed to gain in-depth
insights into the innovation processes, challenges, and outcomes within Poshak Medicines Pvt Ltd.
This design allows for a holistic exploration of the case.
ii) Pohsak Medicines Pvt Ltd: Poshak Medicines will be selected as the sole case study, focusing on its
strategies, practices, and impacts in the realm of poultry healthcare product innovation.
iii) This study will employ a descriptive research design. Descriptive research aims to describe the
characteristics of a phenomenon and present a comprehensive picture of the subject under
investigation.
13
iv) Before full-scale implementation, the questionnaire will undergo pilot testing with a small group
representing the target audience. This aims to identify and rectify any ambiguities or issues in the
survey instrument.
v) The study will adhere to ethical standards, ensuring informed consent from participants.
Confidentiality and anonymity of respondents will be maintained throughout the research process.
2) Data collection methods:
i) Data will be collected through a structured survey. The survey will consist of multiple-choice
questions (MCQs) designed to address the specific objectives of the study.
ii) In-depth Interviews: Key stakeholders within Poshak Medicines, including executives, researchers,
and product development teams, will be interviewed to understand the innovation processes and
decision-making.
iii) Document Analysis: Internal documents such as research reports, product development records,
marketing strategies, and any other relevant materials will be analyzed to gain historical and
contextual perspectives.
iv) Observation: Direct observation of the production and implementation processes of poultry
healthcare products within Poshak Medicines to capture real-time insights.
3) Sampling:
i) The research will use a stratified random sampling technique. Stratification will be based on
categories such as poultry farmers, veterinarians, industry professionals, and existing customers of
Poshak Medicines. The sample size is 110.
ii) Purposeful Sampling: Key informants within Poshak Medicines, including those directly involved in
product development, marketing, and decision-making processes, will be purposively selected.
iii) Maximum Variation Sampling: Ensuring a diverse range of participants to capture varied
perspectives and experiences related to innovation in poultry healthcare products.
14
4) Data analysis tools
i) Coding software: ATLAS.ti, Dedoose software tools facilitate qualitative data coding, categorisation,
and theme identification. Coding software assists in organising and analysing interview transcripts,
documents, and observational notes.
ii) Visualisation tools: Tableau, Microsoft Power BI tools can be employed to create interactive
dashboards and visual representations of quantitative and qualitative data. This aids in presenting
key findings, patterns, and relationships in an accessible manner.
iii) Statistical analysis software: If quantitative data is collected alongside qualitative data, statistical
analysis software can be utilised for quantitative analysis. This may include analysing survey
responses, comparing adoption rates, and identifying statistical relationships.
iv) Data management tools: Microsoft excel, Google sheets, tools are valuable for organising and
managing both qualitative and quantitative data. They can be used for creating datasets, managing
codes, and conducting initial exploratory data analysis.
III) Limitations of the study
1) Single case focus: The study’s exclusive focus on Poshak Medicines Pvt Ltd may restrict the
generalisability of findings to other companies within the poultry healthcare industry. The uniqueness of
the case may limit broader applicability.
2) Subjectivity and bias: Qualitative research inherently involves subjective interpretation. The presence of
personal biases, both from the researcher and participants, may influence the study’s outcomes despite
efforts to minimise subjectivity.
3) Limited quantitative data: The study primarily relies on qualitative data, and the lack of extensive
quantitative data may limit the ability to draw statistically robust conclusions about the impact of
innovations on specific metrics, such as market share or revenue.
15
4) Contextual specificity: Poshak Medicines operates within a specific regional and industry context. The
findings may not fully capture variations in innovation practices in different geographic regions or
diverse market conditions.
5) Interview perspective: The study heavily relies on the perspectives of key stakeholders within Poshak
Medicines. While this provides valuable insights, it may not fully capture the experiences or opinions of
other employees who may contribute to the innovation process.
IV) Rationale of the study
i) Industry significance: The poultry industry is experiencing continuous evolution, with a growing
emphasis on health management. Studying innovations in poultry healthcare products is crucial as it
addresses the industry’s need to adapt to emerging challenges and opportunities.
ii) Poshak medicine’s prominence: Poshak Medicines Pvt Ltd holds a prominent position in the poultry
healthcare sector. Investigating their innovation strategies provides insights into best practices and
can potentially influence industry trends.
iii) Comprehensive product portfolio: Poshak Medicines is involved in the manufacturing of various
poultry healthcare products, including medicines, vaccines, and feed supplements. Exploring their
innovation practices can contribute to a comprehensive understanding of the industry’s product
landscape.
iv) Geographical presence: Poshak Medicines has a wide reach, supplying products to multiple states.
Understanding the geographical impact of their innovations can inform regional practices and
contribute to the overall improvement of poultry health management.
v) Customer centric approach: Poshak Medicines emphasises a seamless customer experience.

Studying their innovation practices allows for insights into how customer-centric strategies are
integrated into the development and delivery of poultry healthcare products.
16
CHAPTER 4: DATA ANALYSIS AND INTERPRETATION
Data analysis based on the responses from the questionnaire.
1) High familiarity and usage: The majority are very familiar with Poshak Medicines, indicating a strong
existing customer base.
2) Positive awareness and perception of innovation: Most respondents are aware of recent innovations, and
while perceptions of innovation are moderately positive, there is room for improvement.
3) Product effectiveness and impact: Positive feedback on product effectiveness and observed impacts
suggests a successful track record in enhancing flock health and productivity.
17
4) High customer satisfaction: The majority of respondents are very satisfied, attributing satisfaction to
various factors like quality, price, and availability.
5) Perceived value and pricing: Respondents generally perceive good value for the cost, indicating a
competitive pricing strategy.
6) Ease of process and information: Positive responses regarding easy access to information and
communication channels contribute to a positive user experience.
7) Areas of improvement: While there are identified areas for improvement, they are minimal, suggesting
overall satisfaction.
8) Future expectations and preferences: Respondents express diverse expectations, including antibiotic-free
solutions, health tracking apps, and digital information access, providing insights into future product
development.
9) Likelihood recommends: A high likelihood to recommend reflects overall satisfaction and positive
experiences with Poshak Medicines’ products.
Interpretation:
The interpretation of the responses suggests an overall positive scenario for Poshak Medicines in the poultry
healthcare sector:
1) Strong customer base: The high familiarity level and product usage indicate a solid existing customer
base, which is beneficial for brand loyalty.
2) Positive awareness and perception: Positive feedback on product effectiveness and observed impacts
indicates that Poshak Medicines’ products have been successful in improving flock health and
productivity.
18
3) High customer satisfaction: The majority expressing very high satisfaction levels suggests that Poshak
Medicines is meeting or exceeding customer expectations in terms of quality, price, and availability.
4) Competitive pricing and value perception: Perceived good value for cost and competitive pricing
suggests that Poshak Medicines has struck a balance between quality and affordability.
5) Effective products and impact: Positive feedback on product effectiveness and observed impacts
indicates that Poshak Medicines’ products have been successful in improving flock health and
productivity.
6) User friendly access to information: Positive feedback on easy access to information and
communication channels reflects a user-friendly approach, contributing to overall customer satisfaction.
7) High likelihood to recommend: The high likelihood of recommending Poshak Medicines’ products
indicates a positive word-of-mouth potential and customer advocacy.
In conclusion, Poshak Medicines appears to have a solid foundation with satisfied customers, effective
products, and room for strategic enhancements based on customer feedback. Continuous innovation and
addressing specific improvement areas can further strengthen their position in the poultry healthcare market.
TABLE 1: AWARENESS AND PERCEPTION OF INNOVATIONS
Particulars % Frequency (out of 110)
Familiarity 80% 88
Usage considerations 87% 96
19
Innovation awareness 66% 73
Innovation comparison 63% 70
TABLE 2: EFFECTIVENESS, SATISFACTION, VALUE PERCEPTION AND RECOMMENDATIONS
Particulars % Frequency (out of 110)
Effectiveness 77.2% 85
Satisfaction 92% 101
Value perception 72% 80
Recommendation likelihood 78% 86
Figure 1: Most significant innovations
20
MOST SIGNIFICANT INNOVATIONS

80
70
60
50
40
30
20
10
0
Specialised health sup- Disease prevention Personalised health plans Sustainability initiatives
plement technologies
Highly innovative Moderately innovative Not innovative
Figures 2: Future innovations expectations
FUTURE INNOVATION EXPECTATIONS
Health tracking app
Antibiotic-feee solution
Digital information access
0% 10% 20% 30% 40% 50% 60% 70%
21
CHAPTER 5: FINDINGS & CONCLUSION, RECOMMENDATIONS, FUTURE
SCOPE OF THE STUDY
Findings
1) Familiarity: 80% of respondents are very familiar with Poshak Medicines.
2) Usage or considerations: 87% have used or considered using Poshak Medicines’ products.
3) Innovative awareness: 66% are aware of recent innovations by Poshak Medicines.
4) Innovative comparison: 63% perceive Poshak Medicines as highly innovative compared to competitors.
5) Effectiveness: 77% find poultry healthcare products from Poshak Medicines very effective.
6) Satisfaction: 92% express high satisfaction with the quality and performance
7) Value perception: 72% perceive good value for the cost of poultry healthcare products.
8) Recommendation likelihood: 78% are likely to recommend Poshak Medicines’ products.
Innovations
1) Specialised health supplement: 52 respondents consider it highly innovative, while 58 perceive it as

moderately innovative.
2) Disease prevention technology: 26 respondents consider it highly innovative, 69 moderately innovative,

and 15 not innovative.
3) Personalised health plans: 70 respondents consider it highly innovative, and 40 moderately innovative.
4) Sustainability initiatives: 66 respondents view it as highly innovative, 23 as moderately innovative, and

21 not innovative.
22
Future innovations expectations
1) Health tracking app: 60% of respondents expect this future innovation.
2) Antibiotic-free solution: 18% express interest in this future innovation.
3) Digital information access: 22% look forward to digital information access.
Conclusion
1) Poshak Medicines enjoys a high level of familiarity and user consideration, with a significant
percentage of satisfied customers.
2) The perception of innovation is strong, especially in disease prevention technology and sustainability
initiatives.
3) Specialised health supplements, disease prevention technology, and personalised health plans are
considered highly innovative by a notable portion of respondents.
4) Future innovations like a health tracking app, antibiotic-free solutions, and digital information access
are anticipated by a considerable percentage of the audience.
5) Overall, Poshak Medicines is well-positioned with positive perceptions, satisfied customers, and a
strong expectation for future innovations. The company’s focus on sustainability is recognised and
appreciated. The findings suggest a solid foundation for continued success and potential growth.
Recommendations
Based on the findings, some of the recommendations for Poshak medicines are:
1) Leverage strong customer satisfaction: With a high satisfaction rate (95%), Poshak Medicines should
capitalize on this positive sentiment by continuing to prioritize product quality, effectiveness, and
customer experience.
23
2) Highlight key innovations: Given that disease prevention technology, personalised health plans, and
sustainability initiatives are perceived as highly innovative, Poshak Medicines should emphasise and
market these features to further differentiate themselves in the market.
3) Enhance awareness of innovations: Despite a high level of satisfaction, there is room to improve
awareness of recent innovations (70%). Implement targeted marketing campaigns, educational
materials, and customer outreach to enhance awareness of the company’s cutting-edge solutions.
4) Address perceived value: While a majority perceive good value for the cost (77%), efforts should be
made to ensure transparency in pricing and communicate the value proposition effectively. Consider
offering promotions or loyalty programs to enhance perceived value.
5) Embrace future innovations: Respond to the anticipated demand for future innovations, especially the
Health Tracking App, Antibiotic-Free Solutions, and Digital Information Access. Investing in these
areas can align with customer expectations and market trends.
6) Act on areas of improvement: Acknowledge and address the areas for improvement identified by
respondents (e.g., 23% mentioning areas for improvement). Gather specific feedback through surveys or
direct communication to pinpoint areas needing attention.
7) Engage customers in sustainable practices: Capitalise on the positive perception of sustainability

initiatives (43%) by actively engaging customers in environmentally friendly practices. Communicate
the company’s commitment to sustainability and involve customers in eco-friendly initiatives.
8) Promote antibiotic free solution: Given the interest in antibiotic-free solutions (18%), Poshak Medicines
could consider expanding or promoting products in this category. This aligns with the growing trend of
health-conscious consumers seeking alternatives to antibiotics.
9) Invest in digital information access: Respond to the interest in digital information access (22%) by
enhancing online platforms, providing informative content, and ensuring easy access to product details.
This can improve the overall customer experience.
10) Continuous customer engagement: Establish ongoing communication channels, gather regular
feedback, and involve customers in the product development process. A continuous feedback loop can
help Poshak Medicines stay responsive to customer needs and preferences.
24
Future scope of the study
The future scope of the study on innovations in poultry healthcare products, with a focus on Poshak Medicines,
can encompass several avenues for further exploration and improvement. Potential directions for future
research might include:
1) Longitudinal study: A longitude study could be conducted to track changes in customer perceptions,
satisfaction, and preferences over time. This could provide insights into the sustainability of positive
trends and the impact of ongoing innovations.
2) Competitor analysis: The study could be extended to include a comprehensive analysis of competitors in
the poultry healthcare industry. Understanding how Poshak Medicines compares to other key players
can provide valuable benchmarks and identify unique selling propositions.
3) Market trends and forecast: Exploring broader market trends and forecasting the future of the poultry
healthcare industry. Investigate emerging technologies, regulatory changes, and consumer behavior
shifts that could impact the industry and influence the development of new products.
4) Global expansion strategies: Investigating potential strategies for global expansion, considering regional
variations in poultry farming practices, healthcare regulations, and market demands. Assessing the
feasibility and potential challenges of entering new markets can guide strategic decisions.
5) Technological integration: Investigating the integration of advanced technologies such as artificial

intelligence, data analytics, and precision farming techniques in poultry healthcare. Assessing how
technological advancements can enhance the effectiveness and efficiency of healthcare products.
6) Customer behaviour analysis: Delving deeper into consumer behaviour by conducting qualitative
research, focus groups, or interviews. Understanding the underlying motivations, preferences, and
decision-making processes of poultry farmers can provide nuanced insights.
7) Environmental impact assessment: Expanding the study to include an environmental impact assessment
of poultry healthcare practices. Evaluating the sustainability initiatives and their effects on the
environment, considering factors such as waste management and resource conservation.
8) Supply chain optimisation: Investigating opportunities for optimising the supply chain, ensuring
efficient distribution and availability of poultry healthcare products. Streamlining logistics and
minimising potential challenges can contribute to overall customer satisfaction.
25
BIBLIOGRAPHY AND REFERENCES
1) https://poshakmedicines.com/services.html
2) https://scholar.google.com/scholar?
hl=en&as_sdt=0%2C5&q=innovations+in+poultry+healthcare+products&btnG=#d=gs_qabs&t=170884
3255220&u=%23p%3DBnOUitxFb20J
3) https://www.veterinariadigital.com/en/articulos/innovation-in-poultry-vaccination-how-to-improve-the-
health-and-performance-of-farm-animals/
hl=en&as_sdt=0%2C5&q=innovations+in+poultry+healthcare+products&btnG=#d=gs_qabs&t=170884
3339449&u=%23p%3D4PKFu5HQ100J
5) https://www.researchgate.net/publication/
332077032_The_Benefits_of_Improving_Animal_Welfare_from_the_Perspective_of_Livestock_Stakeh
olders_across_Asia
6) https://www.researchgate.net/publication/
299387421_Can_feeding_the_broiler_breeder_improve_chick_quality_and_offspring_performance
start=20&q=innovations+in+poultry+healthcare+products&hl=en&as_sdt=0,5#d=gs_qabs&t=17088437
08008&u=%23p%3DuXOah8hdIV0J
24501&u=%23p%3Dh-z-FFE58skJ
42818&u=%23p%3DIIvWWp7XRuYJ
26
59428&u=%23p%3DLKI1f66VJz0J
85986&u=%23p%3DFQjsirt9SOEJ
04656&u=%23p%3D-2xsqymKdHIJ
QUESTIONNAIRE
Q1) How familiar are you with Poshak Medicines and their involvement in the poultry healthcare industry?
a) Very familiar
b) Somewhat familiar
c) Not similar at all
Q2) Have you used or considered using poultry healthcare products from Poshak Medicines? If yes, please
share your experience.
a) Yes
b) No
c) Not sure
Q3) Are you aware of any recent innovations introduced by Poshak Medicines in their poultry healthcare
product line?
a) Yes
b) No
Q4) which one do you think is the most significant innovation of Poshak medicine?
a) Specialised health supplement

b) Disease prevention technology
c) Personalised health plans
d) Sustainability initiatives
27
Q5) How do you perceive the level of innovation in Poshak Medicines compared to other competitors in the
poultry healthcare sector?
a) Highly innovative
b) Moderately innovative
c) Not innovative
Q6) In your experience, how effective are the poultry healthcare products provided by Poshak Medicines in
addressing health challenges in poultry flocks?
a) Very effective
b) Somewhat effective
c) Not effective
Q7) Have you observed any notable impacts on flock health, disease prevention, or overall productivity after
using Poshak Medicines’ products?
a) Yes
b) No
Q8) How satisfied are you with the quality and performance of Poshak Medicines’ poultry healthcare products?
a) Very satisfied
b) Not satisfied
c) Moderately satisfied
Q9) What factors contribute to your satisfaction or dissatisfaction with their products and services?
a) Quality
b) Price
c) Availability
Q10) Do you perceive the poultry healthcare products from Poshak Medicines as providing good value for the
cost?
a) Yes
b) No
c) Neutral
Q11) How do the prices of Poshak Medicines’ products compare to similar offerings in the market?
28
a) Competitive
b) Higher
c) Lower
Q12) How easy is it for you to access information about Poshak Medicines’ poultry healthcare products?
a) Very easy
b) Somewhat easy
c) Neutral
Q13) Do you find their communication channels and product information sufficient and accessible?
a) Yes
b) No
c) Neutral
Q14) Are there specific areas where you believe Poshak Medicines could improve or innovate further in their
poultry healthcare product offerings?
a) Yes
b) No
c) Not sure
Q15) What challenges, if any, have you faced in utilizing or acquiring Poshak Medicines’ products for your
poultry operations?
a) Availability
b) Cost
c) Lack of information
Q16) What features or innovations would you like to see in future poultry healthcare products from Poshak
Medicines?
a) Health tracking app

b) Digital information access
c) Antibiotic free solution
Q17) How important are factors like sustainability, antibiotic-free solutions, and environmental considerations
when choosing poultry healthcare products?
a) Very important
29
b) Moderately improvement
c) Not important
Q18) Overall, how likely are you to recommend Poshak Medicines’ poultry healthcare products to other poultry
farmers or industry professionals?
a) Very likely
b) Somewhat likely
c) Not likely
Q19) Is there anything else you would like to add regarding your experiences or expectations from Poshak
Medicines in the poultry healthcare sector?
a) Yes
b) No
c) Not applicable
30

21BBA111.ET Report Part 2

Uploaded by

Document Information

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

21BBA111.ET Report Part 2

Uploaded by

Copyright:

Available Formats

BM310.

3 - EXECUTIVE TRAINING PROJECT REPORT – PART 2 2024

Executive Training report (Part 2)

Aayush Patel (21BBA111)

Dr. Archana Sarkar

PARTICULARS PAGE NO.

Chapter 1: Introduction and background of study 6

Chapter 4: Data analysis and interpretation 17

CHAPTER 1: INTRODUCTION AND BACKGROUND OF STUDY

Background of the study

CHAPTER 2: LITERATURE REVIEW

CHAPTER 3: RESEARCH METHODOLOGY

I) Objective of the study

8) Determine likelihood to recommend: To investigate any challenges or obstacles faced by respondents in

2) Data collection methods:

4) Data analysis tools

III) Limitations of the study

IV) Rationale of the study

v) Customer centric approach: Poshak Medicines emphasises a seamless customer experience.

CHAPTER 4: DATA ANALYSIS AND INTERPRETATION

Data analysis based on the responses from the questionnaire.

TABLE 1: AWARENESS AND PERCEPTION OF INNOVATIONS

Particulars % Frequency (out of 110)

Usage considerations 87% 96

Innovation comparison 63% 70

TABLE 2: EFFECTIVENESS, SATISFACTION, VALUE PERCEPTION AND RECOMMENDATIONS

Particulars % Frequency (out of 110)

Satisfaction 92% 101

Value perception 72% 80

Recommendation likelihood 78% 86

Figure 1: Most significant innovations

MOST SIGNIFICANT INNOVATIONS

Highly innovative Moderately innovative Not innovative

Figures 2: Future innovations expectations

FUTURE INNOVATION EXPECTATIONS

Health tracking app

Digital information access

0% 10% 20% 30% 40% 50% 60% 70%

1) Familiarity: 80% of respondents are very familiar with Poshak Medicines.

3) Innovative awareness: 66% are aware of recent innovations by Poshak Medicines.

8) Recommendation likelihood: 78% are likely to recommend Poshak Medicines’ products.

1) Specialised health supplement: 52 respondents consider it highly innovative, while 58 perceive it as

2) Disease prevention technology: 26 respondents consider it highly innovative, 69 moderately innovative,

4) Sustainability initiatives: 66 respondents view it as highly innovative, 23 as moderately innovative, and

1) Health tracking app: 60% of respondents expect this future innovation.

2) Antibiotic-free solution: 18% express interest in this future innovation.

3) Digital information access: 22% look forward to digital information access.

7) Engage customers in sustainable practices: Capitalise on the positive perception of sustainability

5) Technological integration: Investigating the integration of advanced technologies such as artificial

a) Specialised health supplement

a) Health tracking app

You might also like